Zhitong Finance App News, Warner Pharmaceuticals (688799.SH) issued an announcement. Recently, Hunan Warner Pharmaceutical Co., Ltd. (“Chiral Drugs”), a wholly-owned subsidiary of the company, received terbutaline sulfate's “Chemical Ingredient Marketing Application Approval Notice” (Notice Number: 2026YS00963) issued by the State Drug Administration and publicized it on the “Original and Auxiliary Package Registration Information” platform of the China Drug Administration (CDE).

Terbutaline sulfate is a raw material for formulations such as terbutaline sulfate solution for atomized inhalation. Terbutaline sulfate nebulized inhalation solution is mainly used to relieve bronchospasm associated with bronchial asthma, chronic bronchitis, emphysema, and other lung diseases.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.